These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 19351367)
1. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
2. Role and prognostic significance of CD44s expression in colorectal cancer. Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD44 expression in colorectal carcinomas. Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Smac/DIABLO expression in colorectal cancer. Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507 [TBL] [Abstract][Full Text] [Related]
7. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264 [TBL] [Abstract][Full Text] [Related]
9. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723 [TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Zlobec I; Günthert U; Tornillo L; Iezzi G; Baumhoer D; Terracciano L; Lugli A Histopathology; 2009 Nov; 55(5):564-75. PubMed ID: 19912362 [TBL] [Abstract][Full Text] [Related]
11. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival. Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728 [TBL] [Abstract][Full Text] [Related]
13. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371 [TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052 [TBL] [Abstract][Full Text] [Related]
16. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715 [TBL] [Abstract][Full Text] [Related]
17. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S Oncology; 2009; 77(1):53-62. PubMed ID: 19556810 [TBL] [Abstract][Full Text] [Related]
18. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623 [TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083 [TBL] [Abstract][Full Text] [Related]
20. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]